2020 Annual Meeting Education Program Webcasts
Description
As the premier event in malignant and non-malignant hematology, the ASH annual meeting provides attendees with an outstanding educational experience that examines the latest clinical advances in hematology and explores the year's most significant scientific discoveries and updates. The videos make this event available for convenient, on-demand viewing.
ASH offers four package options, where you can choose between scientific and educational content, purchase both at a lower price, or purchase the complete meeting including oral abstracts.
The 2020 ASH Annual Meeting Scientific Program package includes all of the following sessions:
• General Sessions
• Scientific Program Sessions
• Special Scientific Symposia
• Special-Interest Sessions
• Spotlight Sessions
• Trainee Simultaneous Didactic Sessions
Access the 2020 ASH Annual Meeting – Invited plus Oral Abstracts for all webcast sessions.
ASH offers four package options, where you can choose between scientific and educational content, purchase both at a lower price, or purchase the complete meeting including oral abstracts.
The 2020 ASH Annual Meeting Scientific Program package includes all of the following sessions:
• General Sessions
• Scientific Program Sessions
• Special Scientific Symposia
• Special-Interest Sessions
• Spotlight Sessions
• Trainee Simultaneous Didactic Sessions
Access the 2020 ASH Annual Meeting – Invited plus Oral Abstracts for all webcast sessions.
Pricing
This meeting is currently not available for purchase.
Sessions
This item is a pre-sale item. The sessions are not live yet. Once you purchase, the sessions will automatically be available to you when the sessions go live.
Complete Meeting-EP
Education Program
- A Map for the Changing Landscape of CLL
- Acute Myeloid Leukemia - So Many Treatment Options; How Do You Decide?
- Advances in the Laboratory Assessment of Hemostatic and Thrombotic Disorders
- Aggressive Lymphomas: What Novel Approaches Are Ready for Prime Time?
- Anxiety Provoking Hematology Consults, Second Edition
- Beyond the Marrow: Major Non-Hematologic Complications of Inherited Bone Marrow Failure Syndromes
- Caring for Patients with Acute Leukemia in Community Hospitals: Who, What, and When to Refer?
- Challenging Situations for Patients with Aggressive Lymphomas
- Chronic Transfusion Support: Challenging Cases
- Diagnostic and Prognostic Models in VTE Management: Ready for Primetime?
- Genetic Testing for Heritable Hematologic Disorders 101
- Handling Challenging Questions in the Management of CML
- Immunotherapy in Multiple Myeloma
- Improving Symptom Control for Children with Hematological Malignancies
- Indolent Lymphomas: Answers to Smoldering Questions
- Infection Risk, Immunization Recommendations, and Antimicrobial Prophylaxis Needs when Treating Non-Malignant Hematologic Disorders - Wash Your Hands and What Else?
- Junior Faculty Career Development Education Session
- Managing Toxicities of Targeted Therapies in CLL
- Monoclonal Gammopathies of Determined Significance
- Myelodysplastic Syndromes: What We Have and What We Want
- Myeloproliferative Disorders: Too Many Cells, Too Few Therapies - How Do We Choose?
- Out of Balance: Anemias Due to Disordered Iron Homeostasis
- Pediatric Hematological Malignancies: CARs for Kids
- Platelet Transfusions for Hematology / Oncology Patients: Taking a More Granular Look
- Selected Hemostasis and Thrombosis Topics in Women
- The Brain and Pain in Sickle Cell Disease: Understanding the Role of Sensory, Cognition and Neuropathic Pathways in the SCD Chronic Pain Experience
- The Emerging Role of Targeted Therapies and Cell Therapy in Transplant
- Understanding How to Manipulate the Immune System in Immunotherapy for Lymphoma
- Updates on the Role of Non-Anticoagulant Interventions in Venous Thromboembolism
- What Hematologists Need to Know About Giving and Stopping Aspirin
- Yin and Yang of Autoimmunity and Immunodeficiencies in Hematology
General Sessions
- ASH Awards Presentation
- ASH-EHA Joint Symposium: Failure of Targeted Cellular Immunotherapy and Hematopoietic Cell Transplant: Mechanisms and Mitigating Strategies
- Best of ASH
- Business Meeting
- E. Donnall Thomas Lecture and Prize
- Ernest Beutler Lecture and Prize
- Fireside Chat with Dr. Anthony Fauci
- Ham-Wasserman Lecture
- Late-Breaking Abstracts Session
- Plenary Scientific Session
- Presidential Symposium: Universal Donor Solutions in Hematology
Special Scientific Symposia
Special-Interest Sessions
- ASH Choosing Wisely� Campaign: 2020 ASH Choosing Wisely Champions
- Blood & Beyond
- Modeling COVID-19: From the Lab to the World
- Special Scientific Session on Race and Science
- Special Symposium on Quality: Blood, Debt and Tears: Tackling Burnout in Hematology
- The 2020 Pandemic: Latest Insights on COVID-19
Spotlight Sessions
- Appropriate Use of Imaging in Patients with Lymphoma
- Cellular Breakups: Transfusion and Hyperhemolysis in Sickle Cell Disease
- Checkpoint Blockade: Defining A New Treatment Paradigm in Hodgkin Lymphoma and Allogeneic Transplantation
- Emicizumab�s Impact on the Landscape of Hemophilia A Treatment: Two Artists Debate the View
- How to Manage Common Challenging Situations in Patients with Multiple Myeloma
- Transfusion and Anemia in Global Health
- Vascular Anomalies 101: Case-Based Discussion on the Diagnosis, Treatment and Lifelong Care of These Patients
Trainee Activities and Services
ASH Meeting on Hematologic Malignancies
Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.
Learn more
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
Copyright © 2021 by American Society of Hematology